Blood clot test using fresh plasma in adults with suspected venous thromboembolism
Compares a decision-support blood test on fresh and frozen plasma in suspected blood clots.
Key facts
- Who runs it
- Diagnostica Stago R&D
- Where
- France4 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
- Status
- Recruiting
- People taking part
- 1,836 people, planned
- Started
- 21 Jun 2022
- Expected to end
- Feb 2027
- Type of study
- Observational
- Treatments tested
- Routine Assays on fresh plasma
- New Clinical Decision Support on fresh plasma
- New Clinical Decision Support on frozen plasma
- Record updated
- 26 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who may have a blood clot in the lung (pulmonary embolism) or in a deep vein (deep vein thrombosis). It tests a new decision tool on fresh blood plasma.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Suspected pulmonary embolism and/or deep vein thrombosis, whatever the chance of having it before testing.
- Earlier treatment
- People cannot join if they are taking blood thinners, either to prevent or to treat clots, or clot-dissolving treatment.
Main reasons for not taking part
- Taking blood thinners to prevent or treat clots
- Taking clot-dissolving (fibrinolytic) treatment
- Under legal protection, such as guardianship or curatorship
- Pregnant or breastfeeding women
- Not covered by the social security system
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- PE and/or DVT suspicion
- No opposition after informing the patient for his participation in research and processing of their data for this purpose,
- Benefiting from the social security system
Who cannot take part
- Preventive or curative anticoagulant treatment, or fibrinolytic treatment,
- Legal protection (e.g. guardianship or curatorship),
- Pregnant or breastfeeding women
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this non interventional study is to demonstrate the diagnostic performances on fresh plasmas in comparison with the performances on frozen plasmas in any patients with VTE suspicion, whatever the pre-test probability. The main question it aims to answer is :
Read full original descriptionShow less
Are the performances equivalent on fresh plasmas in comparison with frozen plasmas or is it necessary to determine a new algorithm of the Clinical Decision Support with a new cut-off? Participants will be diagnosed and treated in accordance with routine standard of care.
Treatments tested
- Routine Assays on fresh plasma
- New Clinical Decision Support on fresh plasma
- New Clinical Decision Support on frozen plasma
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support With Fresh Plasma, on Any Patient With VTE Suspicion
- Plain-language title
- Blood clot test using fresh plasma in adults with suspected venous thromboembolismGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 26 June 2025